Suppr超能文献

Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.

作者信息

Chen Robert T, Hu Dale J, Dunne Eileen, Shaw Michael, Mullins James I, Rerks-Ngarm Supachai

机构信息

Centers for Disease Control and Prevention, Atlanta, GA 30333, United States.

出版信息

Vaccine. 2011 Aug 18;29(36):6072-8. doi: 10.1016/j.vaccine.2011.07.015. Epub 2011 Jul 13.

Abstract
摘要

相似文献

1
Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.
Vaccine. 2011 Aug 18;29(36):6072-8. doi: 10.1016/j.vaccine.2011.07.015. Epub 2011 Jul 13.
2
HIV/AIDS Vaccines: 2018.
Clin Pharmacol Ther. 2018 Dec;104(6):1062-1073. doi: 10.1002/cpt.1208. Epub 2018 Oct 9.
3
DNA gene vaccination for HIV.
Springer Semin Immunopathol. 1997;19(2):175-94. doi: 10.1007/BF00870267.
4
Efficacy trials for HIV/AIDS vaccines.
AIDS Res Hum Retroviruses. 1992 Aug;8(8):1527-9. doi: 10.1089/aid.1992.8.1527.
5
Current situation in the development of a preventive HIV vaccine.
Enferm Infecc Microbiol Clin. 2005 Jul;23 Suppl 2:5-24. doi: 10.1016/S0213-005X(05)75156-9.
7
HIV-1 diversity and vaccine development.
Science. 2002 Jun 28;296(5577):2335. doi: 10.1126/science.296.5577.2335.
8
Human versus HIV: round 2 defeat in AIDS vaccine development.
Expert Rev Vaccines. 2008 Mar;7(2):151-3. doi: 10.1586/14760584.7.2.151.
9
Immunology. Immune activation with HIV vaccines.
Science. 2014 Apr 4;344(6179):49-51. doi: 10.1126/science.1250672.
10
HIV HGP-30W vaccine (Cel-Sci).
Drugs R D. 1999 Jun;1(6):453-5. doi: 10.2165/00126839-199901060-00007.

引用本文的文献

1
HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.
Vaccine. 2018 Jan 25;36(4):514-520. doi: 10.1016/j.vaccine.2017.12.004. Epub 2017 Dec 11.
3
Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical Models.
EBioMedicine. 2015 Nov 5;2(12):2062-9. doi: 10.1016/j.ebiom.2015.11.009. eCollection 2015 Dec.
4
Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward.
AIDS Patient Care STDS. 2015 Jul;29(7):389-99. doi: 10.1089/apc.2014.0348. Epub 2015 May 18.

本文引用的文献

1
Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes.
J Virol. 2011 Aug;85(15):7523-34. doi: 10.1128/JVI.02697-10. Epub 2011 May 18.
2
HIV Vaccine efficacy trial: glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity.
Hum Vaccin. 2011 Apr;7(4):466-73. doi: 10.4161/hv.7.4.14123. Epub 2011 Apr 1.
3
Sustaining GAVI-supported vaccine introductions in resource-poor countries.
Vaccine. 2011 Apr 12;29(17):3149-54. doi: 10.1016/j.vaccine.2011.02.042. Epub 2011 Feb 24.
5
Patient-provider communication and human papillomavirus vaccine acceptance.
Clin Pediatr (Phila). 2011 Feb;50(2):106-13. doi: 10.1177/0009922810379907. Epub 2010 Sep 13.
7
HPV vaccination mandates--lawmaking amid political and scientific controversy.
N Engl J Med. 2010 Aug 19;363(8):785-91. doi: 10.1056/NEJMsr1003547.
9
Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience.
Clin Liver Dis. 2010 Aug;14(3):521-30. doi: 10.1016/j.cld.2010.05.010.
10
Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005.
Vaccine. 2010 Aug 23;28(37):5973-8. doi: 10.1016/j.vaccine.2010.06.111. Epub 2010 Jul 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验